肠道微生物群与自然生物活性多糖在代谢疾病中的相互作用:综述
Yu Pi1, Miaoyu Fang2, Yanpin Li1
1Key Laboratory of Feed Biotechnology of Ministry of Agriculture and Rural Affairs, Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
来自自然来源的生物活性多糖 (BPs) 与肠道微生物群相互作用,影响人类健康. 了解这种关系为预防和治疗代谢性疾病提供了新的途径.
科学领域:
- 微生物学与营养学
- 肠道微生物群和健康
- 自然产品化学 自然产品化学
背景情况:
- 人的肠道微生物群是一个复杂的生态系统,对健康至关重要.
- 饮食显著影响肠道微生物群的组成和功能.
- 来自自然来源的生物活性多糖 (BPs) 具有多种健康益处.
研究的目的:
- 审查人类肠道微生物群在代谢疾病中的作用.
- 探索BP的特征和肠道微生物群相互作用.
- 总结BP的健康益处,重点关注代谢调节.
主要方法:
- 关于肠道微生物群,BP和代谢疾病的研究的文献综述.
- 分析BP结构及其通过肠道微生物的代谢.
- 对血压对免疫调节,血糖和脂质特征的影响的综合证据.
主要成果:
- BPs调节肠道微生物群的组成和活性.
- 肠道微生物对BP的代谢产生有益的化合物.
- 蛋白质蛋白显示出显著的免疫调节,降血糖和降脂效应.
结论:
- 乙醇是预防和治疗代谢性疾病的有前途的天然剂.
- 了解BP-肠道微生物群相互作用是开发向治疗的关键.
- 对这些机制的进一步研究可以改善代谢健康策略.
更多相关视频
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
00:06Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
相关概念视频
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
What is Monogastric Digestion?
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
